Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?

por Gao, Rui, Reece, Kelie M, Sissung, Tristan, Fu, Samuel H, Venzon, David J, Reed, Eddie, Spencer, Shawn D, Price, Douglas K, Figg, William D
Publicado 2013

Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy

por Lee, Kin Sing Stephen, Liu, Jun-Yan, Wagner, Karen M., Pakhomova, Svetlana, Dong, Hua, Morisseau, Christophe, Fu, Samuel H., Yang, Jun, Wang, Peng, Ulu, Arzu, Mate, Christina A., Nguyen, Long V., Hwang, Sung Hee, Edin, Matthew L., Mara, Alexandria A., Wulff, Heike, Newcomer, Marcia E., Zeldin, Darryl C., Hammock, Bruce D.
Publicado 2014

Correction to Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo Efficacy

por Lee, Kin Sing Stephen, Liu, Jun-Yan, Wagner, Karen M., Pakhomova, Svetlana, Dong, Hua, Morisseau, Christophe, Fu, Samuel H., Yang, Jun, Wang, Peng, Ulu, Arzu, Mate, Christina A., Nguyen, Long V., Hwang, Sung Hee, Edin, Matthew L., Mara, Alexandria A., Wulff, Heike, Newcomer, Marcia E., Zeldin, Darryl C., Hammock, Bruce D.
Publicado 2018